Pharmaceutical stocks start in the laboratory. But not all l...

Pharmaceutical stocks start in the laboratory. But not all laboratories are successful. But all laboratories need equipment.

Laboratory equipment is only a small part of the work done by TMO. The real income comes from consumables (culture media, reagents, etc.), which account for more than 50% of its income. Instrumentation is only ~20%. Pharmaceutical companies need large amounts of materials to manufacture and process their products year after year. Having said that, TMO is a good buy and hold stock. They will never disappear and will continue to expand through acquisitions to cover the entire pharmaceutical supply chain.
Fun fact: They also own Nalgene, which is a popular water bottle brand.